Long-term Mortality in Diabetics Undergoing Major Surgery
Comparison in Survival in Patients With Insulin-dependent and Non-insulin-dependent Diabetes Mellitus With Known or Suspected Coronary Artery Disease Undergoing Major Non-cardiac Surgery
1 other identifier
observational
380
1 country
1
Brief Summary
Patients with CAD and diabetes mellitus have a better prognosis than patients with CAD and no diabetes mellitus. In acute coronary syndrome patients with an insulin therapy had a better survival than patients with oral antidiabetics. But there is not known wether perioperative therapy with insulin or oral antidiabetics is associated with higher risk for higher perioperative cardiac morbidity and mortality and worse long-term survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
February 2, 2006
CompletedFirst Posted
Study publicly available on registry
February 3, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedMarch 10, 2015
March 1, 2015
5.6 years
February 2, 2006
March 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death and/or major adverse cardiac events
12 months after surgery
Eligibility Criteria
Patients with treated diabetes mellitus undergoing surgery with major risk or patients with treated diabetes mellitus and known coronary artery disease undergoing surgery with major or intermediate risk
You may qualify if:
- diabetes mellitus with insulin or oral antidiabetics
- proven coronary artery disease or very high risk for it
- major non-vascular surgery
You may not qualify if:
- emergency
- no consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Basel, CH, 4000, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miodrag Filipovic, PD Dr.
University Hospital, Basel, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PD Dr. Daniel Bolliger
Study Record Dates
First Submitted
February 2, 2006
First Posted
February 3, 2006
Study Start
January 1, 2004
Primary Completion
August 1, 2009
Study Completion
August 1, 2010
Last Updated
March 10, 2015
Record last verified: 2015-03